ATE513555T1 - Pharmazeutische kombination aus g-csf und plgf für blutstammzellen - Google Patents
Pharmazeutische kombination aus g-csf und plgf für blutstammzellenInfo
- Publication number
- ATE513555T1 ATE513555T1 AT04763431T AT04763431T ATE513555T1 AT E513555 T1 ATE513555 T1 AT E513555T1 AT 04763431 T AT04763431 T AT 04763431T AT 04763431 T AT04763431 T AT 04763431T AT E513555 T1 ATE513555 T1 AT E513555T1
- Authority
- AT
- Austria
- Prior art keywords
- csf
- stem cells
- plgf
- blood stem
- pharmaceutical combination
- Prior art date
Links
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 title abstract 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 title abstract 2
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 210000000130 stem cell Anatomy 0.000 title abstract 2
- 101150062285 PGF gene Proteins 0.000 title 1
- 102100035194 Placenta growth factor Human genes 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03017174 | 2003-07-29 | ||
| PCT/EP2004/008245 WO2005014023A1 (en) | 2003-07-29 | 2004-07-23 | Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE513555T1 true ATE513555T1 (de) | 2011-07-15 |
Family
ID=34130041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04763431T ATE513555T1 (de) | 2003-07-29 | 2004-07-23 | Pharmazeutische kombination aus g-csf und plgf für blutstammzellen |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20070036747A1 (de) |
| EP (1) | EP1660115B1 (de) |
| JP (1) | JP4855253B2 (de) |
| KR (1) | KR101192136B1 (de) |
| CN (1) | CN100534528C (de) |
| AT (1) | ATE513555T1 (de) |
| AU (1) | AU2004262909B2 (de) |
| BR (1) | BRPI0412989A (de) |
| CA (1) | CA2526244C (de) |
| DK (1) | DK1660115T3 (de) |
| ES (1) | ES2369487T3 (de) |
| IL (1) | IL173369A (de) |
| MX (1) | MXPA06000017A (de) |
| NO (1) | NO20060955L (de) |
| NZ (1) | NZ543612A (de) |
| PL (1) | PL1660115T3 (de) |
| PT (1) | PT1660115E (de) |
| RU (1) | RU2351357C2 (de) |
| SI (1) | SI1660115T1 (de) |
| WO (1) | WO2005014023A1 (de) |
| ZA (1) | ZA200509361B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2206719E (pt) | 2005-03-02 | 2015-02-05 | Univ Maryland | Composição farmacêutica compreendendo 3-beta-hidroxi-17- (1-h-benzimidazol-1-il)androsta-5,16-dieno |
| US20100048524A1 (en) | 2008-03-14 | 2010-02-25 | Angela Brodie | Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity |
| GB2470700B (en) | 2008-03-25 | 2012-08-08 | Univ Maryland | C-17 heteroaryl steroidal CYP17 inhibitors |
| US8785423B2 (en) | 2008-04-14 | 2014-07-22 | University Of Maryland, Baltimore | Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases |
| WO2010091306A1 (en) | 2009-02-05 | 2010-08-12 | Tokai Pharmaceuticals | Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| US8791095B2 (en) | 2009-02-05 | 2014-07-29 | Tokai Pharmaceuticals, Inc. | Steroidal CYP17 inhibitors/antiandrogens |
| BR112012002797A2 (pt) | 2009-08-07 | 2019-09-24 | Tokai Pharmaceuticals Inc | tratamento de câncer de próstata |
| KR20160023638A (ko) | 2013-02-28 | 2016-03-03 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 줄기세포를 이동하기 위한 방법 및 조성물 |
| EP2968370A4 (de) | 2013-03-14 | 2016-09-21 | Univ Maryland | Mittel zur androgenrezeptor-abwärtsregelung und verwendungen davon |
| EP3033088A4 (de) | 2013-08-12 | 2017-03-08 | Tokai Pharmaceuticals, Inc. | Biomarker zur behandlung neoplastischer störungen mit androgen-anzielenden therapien |
| LT6161B (lt) | 2013-09-27 | 2015-06-25 | Uab Profarma | Granuliocitų kolonijas stimuliuojančio faktoriaus sulieti baltymai su kitais augimo faktoriais, optimaliai su kamieninių ląstelių faktoriumi, ir jų gavimo būdas |
| CN114891746A (zh) * | 2021-12-21 | 2022-08-12 | 青岛今墨堂生物技术有限公司 | 一种犬全血造血干细胞的制备方法 |
| WO2023133595A2 (en) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2024081820A1 (en) | 2022-10-13 | 2024-04-18 | Sana Biotechnology, Inc. | Viral particles targeting hematopoietic stem cells |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| AU2024274792A1 (en) | 2023-05-23 | 2025-10-23 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| US5773252A (en) * | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
| DE19549232C2 (de) * | 1995-12-20 | 1998-05-20 | Boehringer Mannheim Gmbh | Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum bei der Behandlung von Erkrankungen, die eine periphere Stammzelltransplantation erfordern |
| US7105168B1 (en) * | 2002-06-04 | 2006-09-12 | D. Collen Research Foundation Vzw | Method of improving ischemic muscle function by administering placental growth factor |
| EP1147777A1 (de) * | 2000-04-18 | 2001-10-24 | Crinos Industria Farmacobiologica S.p.A. | Kombination von Defibrotid und G-CSF und ihre Verwendung zur Aktivierung der hämatopoiestischen Vorläuferzellen |
| KR20030034177A (ko) * | 2000-09-13 | 2003-05-01 | 쥬가이 세이야쿠 가부시키가이샤 | 허혈성 질환 치료제 |
| DE10234192B4 (de) * | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
| EP1594527A2 (de) * | 2003-02-04 | 2005-11-16 | Ludwig Institute For Cancer Research | Vegf-b und pdgf modulierung von stammzellen |
-
2004
- 2004-07-23 WO PCT/EP2004/008245 patent/WO2005014023A1/en not_active Ceased
- 2004-07-23 SI SI200431743T patent/SI1660115T1/sl unknown
- 2004-07-23 AU AU2004262909A patent/AU2004262909B2/en not_active Ceased
- 2004-07-23 AT AT04763431T patent/ATE513555T1/de active
- 2004-07-23 KR KR1020057023606A patent/KR101192136B1/ko not_active Expired - Fee Related
- 2004-07-23 MX MXPA06000017A patent/MXPA06000017A/es active IP Right Grant
- 2004-07-23 RU RU2006106228/15A patent/RU2351357C2/ru not_active IP Right Cessation
- 2004-07-23 EP EP04763431A patent/EP1660115B1/de not_active Expired - Lifetime
- 2004-07-23 BR BRPI0412989-0A patent/BRPI0412989A/pt not_active IP Right Cessation
- 2004-07-23 PT PT04763431T patent/PT1660115E/pt unknown
- 2004-07-23 PL PL04763431T patent/PL1660115T3/pl unknown
- 2004-07-23 DK DK04763431.6T patent/DK1660115T3/da active
- 2004-07-23 ES ES04763431T patent/ES2369487T3/es not_active Expired - Lifetime
- 2004-07-23 NZ NZ543612A patent/NZ543612A/en not_active IP Right Cessation
- 2004-07-23 ZA ZA200509361A patent/ZA200509361B/en unknown
- 2004-07-23 JP JP2006521487A patent/JP4855253B2/ja not_active Expired - Fee Related
- 2004-07-23 CN CNB2004800213159A patent/CN100534528C/zh not_active Expired - Fee Related
- 2004-07-23 US US10/565,903 patent/US20070036747A1/en not_active Abandoned
- 2004-07-23 CA CA2526244A patent/CA2526244C/en not_active Expired - Fee Related
-
2006
- 2006-01-26 IL IL173369A patent/IL173369A/en not_active IP Right Cessation
- 2006-02-27 NO NO20060955A patent/NO20060955L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06000017A (es) | 2006-03-21 |
| JP2007500157A (ja) | 2007-01-11 |
| ZA200509361B (en) | 2007-03-28 |
| RU2006106228A (ru) | 2007-09-10 |
| NZ543612A (en) | 2008-03-28 |
| KR20060079753A (ko) | 2006-07-06 |
| PL1660115T3 (pl) | 2011-11-30 |
| CN1826134A (zh) | 2006-08-30 |
| NO20060955L (no) | 2006-02-27 |
| DK1660115T3 (da) | 2011-10-10 |
| IL173369A (en) | 2010-12-30 |
| ES2369487T3 (es) | 2011-12-01 |
| SI1660115T1 (sl) | 2011-10-28 |
| EP1660115A1 (de) | 2006-05-31 |
| BRPI0412989A (pt) | 2006-10-03 |
| EP1660115B1 (de) | 2011-06-22 |
| JP4855253B2 (ja) | 2012-01-18 |
| AU2004262909A1 (en) | 2005-02-17 |
| RU2351357C2 (ru) | 2009-04-10 |
| CA2526244A1 (en) | 2005-02-17 |
| WO2005014023A1 (en) | 2005-02-17 |
| KR101192136B1 (ko) | 2012-10-16 |
| PT1660115E (pt) | 2011-08-24 |
| CN100534528C (zh) | 2009-09-02 |
| CA2526244C (en) | 2012-03-20 |
| AU2004262909B2 (en) | 2010-07-01 |
| US20070036747A1 (en) | 2007-02-15 |
| IL173369A0 (en) | 2006-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173369A0 (en) | Pharmaceutical combination of g-csf and plgf useful for blood stem cell | |
| NO20063430L (no) | Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering | |
| DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| NO2014028I2 (no) | Glukopyranosyl-substituerte benzenderivater, fremgangsmåte for fremstilling av disse, fysiologisk akseptable salter av slike forbindelser, medikamenter inneholdende slike forbindelser og kombinasjoner med andre aktive substanser samt deresanvendelse for fremstilling av medikamenter for behandling av sykdom | |
| TW200605870A (en) | Topical methadone compositions and methods for using the same | |
| DE60213114D1 (de) | Herbizidzusammensetzung,umfassend herbizide verbindung in säureform und ansäuerndes mittel,applizierverfahren und herstellungsverfahren davon | |
| EA200600164A1 (ru) | Цеолиты для дозирования оксида азота | |
| WO2004089396A3 (en) | Anti-fungal peptidomimetics | |
| DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| FR2867684B1 (fr) | Gel creme contenant de l'ivermectine | |
| DK2076588T3 (da) | Ekspansionsfremgangsmåde til voksne stamceller fra blod, især perifert blod, og dermed forbundet anvendelse på det medicinske område | |
| FR2889811B1 (fr) | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. | |
| MXPA05012319A (es) | Suministro de compuestos con celulas sanguineas rehidratadas. | |
| BRPI0311189B8 (pt) | composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| MA29030B1 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation | |
| EA200602047A1 (ru) | Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака | |
| IL163900A (en) | Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody | |
| ITMI20031396A1 (it) | Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante. | |
| DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
| SE0300457D0 (sv) | Novel compounds | |
| FR2883184B1 (fr) | Composition de spirulines riche en principes actifs, procede d'obtention et utilisation | |
| ATE487492T1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
| BRPI0616535B8 (pt) | uso de fator de tecido (tf) lipidado ou um fragmento funcional do mesmo, produto, uso de um produto, complexo (tf::fxa), uso de um complexo, complexo tf::ncis, complexo tf::fxa:ncis, composição farmacêutica e uso de tf não-lipidado ou um fragmento funcional do mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1660115 Country of ref document: EP |